pI: 5.8609 |
Length (AA): 1607 |
MW (Da): 183624 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 11 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
984 | 1501 | 1omw (A) | 30 | 552 | 19.00 | 0 | 1 | 0.38 | 0.02 |
1005 | 1417 | 1k9a (A) | 26 | 442 | 18.00 | 0 | 1 | 0.27 | 0.05 |
1212 | 1421 | 1cm8 (A) | 74 | 312 | 35.00 | 0 | 1 | 0.52 | -1.8 |
1 | 104 | 2fxo (A) | 859 | 963 | 12.00 | 0.38 | 0 | 0.182517 | -0.32 |
6 | 178 | 5cwk (A) | 3 | 172 | 15.00 | 0.43 | 0.04 | 0.295454 | -0.78 |
1064 | 1449 | 4w7p (A) | 6 | 371 | 24.00 | 0 | 1 | 0.313099 | 0.85 |
1138 | 1606 | 3lij (A) | 38 | 512 | 32.00 | 0 | 1 | 0.647748 | -0.38 |
1159 | 1422 | 3is5 (A) | 126 | 395 | 50.00 | 0 | 1 | 0.696181 | -0.24 |
1429 | 1607 | 3mse (B) | 1 | 179 | 76.00 | 0 | 1 | 0.972688 | -0.8 |
1464 | 1523 | 4gft (A) | 140 | 199 | 17.00 | 0.024 | 0.99 | 0.407237 | -1.53 |
1469 | 1539 | 1gjy (A) | 106 | 176 | 20.00 | 0.008 | 0.52 | 0.339082 | -1.15 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intraerythrocytic - 48 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intraerythrocytic - 6 hs, intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 24 hs, intraerythrocytic - 30 hs, intraerythrocytic - 36 hs, intraerythrocytic - 40 hs. | Zhu L |
Zhu L | New insights into the Plasmodium vivax transcriptome using RNA-Seq. |
Ortholog group members (OG5_146625)
Species | Accession | Gene Product |
---|---|---|
Cryptosporidium hominis | Chro.40377 | hypothetical protein |
Cryptosporidium parvum | cgd4_3330 | hypothetical protein |
Neospora caninum | NCLIV_061660 | CAM kinase, CDPK family, putative |
Plasmodium berghei | PBANKA_0925500 | calcium-dependent protein kinase 6 |
Plasmodium falciparum | PF3D7_1122800 | calcium-dependent protein kinase 6 |
Plasmodium knowlesi | PKNH_0920600 | calcium-dependent protein kinase 6, putative |
Plasmodium vivax | PVX_091755 | calcium-dependent protein kinase 6, putative |
Plasmodium yoelii | PY04265 | Plasmodium falciparum CDPK2 protein-related |
Toxoplasma gondii | TGME49_218720 | calcium-dependent protein kinase CDPK6 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_0925500 | Plasmodium berghei | Slow | plasmo |
TGME49_218720 | Toxoplasma gondii | Essentiality uncertain | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 27.3% | 289 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 28.0% | 239 aa | Compounds | References |
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 31.4% | 156 aa | Compounds | References |
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 28.1% | 292 aa | Compounds | References |
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 25.9% | 301 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 28.5% | 246 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 26.3% | 293 aa | Compounds | References |
Zea mays | CaM kinase I alpha | 492 aa | 29.7% | 414 aa | Compounds | References |